位置:首页 > 蛋白库 > VEGFD_HUMAN
VEGFD_HUMAN
ID   VEGFD_HUMAN             Reviewed;         354 AA.
AC   O43915; B2R7Z3;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Vascular endothelial growth factor D {ECO:0000312|HGNC:HGNC:3708};
DE            Short=VEGF-D;
DE   AltName: Full=c-Fos-induced growth factor;
DE            Short=FIGF;
DE   Flags: Precursor;
GN   Name=VEGFD {ECO:0000312|HGNC:HGNC:3708}; Synonyms=FIGF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=9205122; DOI=10.1006/geno.1997.4774;
RA   Yamada Y., Nezu J., Shimane M., Hirata Y.;
RT   "Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.";
RL   Genomics 42:483-488(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Lung;
RX   PubMed=9479493; DOI=10.1006/geno.1997.5079;
RA   Rocchigiani M., Lestingi M., Luddi A., Orlandini M., Franco B., Rossi E.,
RA   Ballabio A., Zuffardi O., Oliviero S.;
RT   "Human FIGF: cloning, gene structure, and mapping to chromosome Xp22.1
RT   between the PIGA and the GRPR genes.";
RL   Genomics 47:207-216(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9435229; DOI=10.1073/pnas.95.2.548;
RA   Achen M.G., Jeltsch M., Kukk E., Maekinen T., Vitali A., Wilks A.F.,
RA   Alitalo K., Stacker S.A.;
RT   "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine
RT   kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:548-553(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 89-94; 100-105 AND 206-213, AND PROTEOLYTIC PROCESSING.
RX   PubMed=10542248; DOI=10.1074/jbc.274.45.32127;
RA   Stacker S.A., Stenvers K.L., Caesar C., Vitali A., Domagala T., Nice E.C.,
RA   Roufail S., Simpson R.J., Moritz R., Karpanen T., Alitalo K., Achen M.G.;
RT   "Biosynthesis of vascular endothelial growth factor-D involves proteolytic
RT   processing which generates non-covalent homodimers.";
RL   J. Biol. Chem. 274:32127-32136(1999).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 92-195 OF MUTANT ALA-117,
RP   FUNCTION, SUBUNIT, GLYCOSYLATION AT ASN-155 AND ASN-185, AND DISULFIDE
RP   BONDS.
RX   PubMed=21148085; DOI=10.1182/blood-2010-08-301549;
RA   Leppanen V.M., Jeltsch M., Anisimov A., Tvorogov D., Aho K., Kalkkinen N.,
RA   Toivanen P., Yla-Herttuala S., Ballmer-Hofer K., Alitalo K.;
RT   "Structural determinants of vascular endothelial growth factor-D - receptor
RT   binding and specificity.";
RL   Blood 117:1507-1515(2011).
CC   -!- FUNCTION: Growth factor active in angiogenesis, lymphangiogenesis and
CC       endothelial cell growth, stimulating their proliferation and migration
CC       and also has effects on the permeability of blood vessels. May function
CC       in the formation of the venous and lymphatic vascular systems during
CC       embryogenesis, and also in the maintenance of differentiated lymphatic
CC       endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and
CC       VEGFR-3 (FLT4) receptors. {ECO:0000269|PubMed:21148085}.
CC   -!- SUBUNIT: Homodimer; non-covalent and antiparallel.
CC       {ECO:0000269|PubMed:21148085}.
CC   -!- INTERACTION:
CC       O43915; Q15836: VAMP3; NbExp=4; IntAct=EBI-11750035, EBI-722343;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung, heart, small intestine
CC       and fetal lung, and at lower levels in skeletal muscle, colon, and
CC       pancreas.
CC   -!- PTM: Undergoes a complex proteolytic maturation which generates a
CC       variety of processed secreted forms with increased activity toward
CC       VEGFR-3 and VEGFR-2. VEGF-D first form an antiparallel homodimer linked
CC       by disulfide bonds before secretion. The fully processed VEGF-D is
CC       composed mostly of two VEGF homology domains (VHDs) bound by non-
CC       covalent interactions. {ECO:0000269|PubMed:10542248}.
CC   -!- SIMILARITY: Belongs to the PDGF/VEGF growth factor family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FIGFID40574chXp22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D89630; BAA24264.1; -; mRNA.
DR   EMBL; Y12863; CAA73370.1; -; mRNA.
DR   EMBL; Y12864; CAA73371.1; -; Genomic_DNA.
DR   EMBL; Y12865; CAA73371.1; JOINED; Genomic_DNA.
DR   EMBL; Y12866; CAA73371.1; JOINED; Genomic_DNA.
DR   EMBL; Y12867; CAA73371.1; JOINED; Genomic_DNA.
DR   EMBL; Y12868; CAA73371.1; JOINED; Genomic_DNA.
DR   EMBL; Y12869; CAA73371.1; JOINED; Genomic_DNA.
DR   EMBL; Y12870; CAA73371.1; JOINED; Genomic_DNA.
DR   EMBL; AJ000185; CAA03942.1; -; mRNA.
DR   EMBL; AK313173; BAG35990.1; -; mRNA.
DR   EMBL; CH471074; EAW98885.1; -; Genomic_DNA.
DR   EMBL; BC027948; AAH27948.1; -; mRNA.
DR   CCDS; CCDS14166.1; -.
DR   RefSeq; NP_004460.1; NM_004469.4.
DR   PDB; 2XV7; X-ray; 2.90 A; A=92-195.
DR   PDBsum; 2XV7; -.
DR   AlphaFoldDB; O43915; -.
DR   SMR; O43915; -.
DR   BioGRID; 108567; 57.
DR   CORUM; O43915; -.
DR   IntAct; O43915; 6.
DR   STRING; 9606.ENSP00000297904; -.
DR   GlyGen; O43915; 4 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; O43915; -.
DR   PhosphoSitePlus; O43915; -.
DR   BioMuta; VEGFD; -.
DR   MassIVE; O43915; -.
DR   PaxDb; O43915; -.
DR   PeptideAtlas; O43915; -.
DR   PRIDE; O43915; -.
DR   ProteomicsDB; 49231; -.
DR   Antibodypedia; 8816; 622 antibodies from 37 providers.
DR   DNASU; 2277; -.
DR   Ensembl; ENST00000297904.4; ENSP00000297904.3; ENSG00000165197.5.
DR   GeneID; 2277; -.
DR   KEGG; hsa:2277; -.
DR   MANE-Select; ENST00000297904.4; ENSP00000297904.3; NM_004469.5; NP_004460.1.
DR   UCSC; uc004cwt.3; human.
DR   CTD; 2277; -.
DR   DisGeNET; 2277; -.
DR   GeneCards; VEGFD; -.
DR   HGNC; HGNC:3708; VEGFD.
DR   HPA; ENSG00000165197; Tissue enhanced (lung).
DR   MIM; 300091; gene.
DR   neXtProt; NX_O43915; -.
DR   OpenTargets; ENSG00000165197; -.
DR   PharmGKB; PA28146; -.
DR   VEuPathDB; HostDB:ENSG00000165197; -.
DR   eggNOG; ENOG502QVIH; Eukaryota.
DR   GeneTree; ENSGT00940000159726; -.
DR   HOGENOM; CLU_061712_0_0_1; -.
DR   InParanoid; O43915; -.
DR   OMA; FHTRTCA; -.
DR   OrthoDB; 1364454at2759; -.
DR   PhylomeDB; O43915; -.
DR   TreeFam; TF319554; -.
DR   BRENDA; 3.4.21.46; 2681.
DR   PathwayCommons; O43915; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-194313; VEGF ligand-receptor interactions.
DR   Reactome; R-HSA-195399; VEGF binds to VEGFR leading to receptor dimerization.
DR   SignaLink; O43915; -.
DR   SIGNOR; O43915; -.
DR   BioGRID-ORCS; 2277; 8 hits in 694 CRISPR screens.
DR   ChiTaRS; VEGFD; human.
DR   EvolutionaryTrace; O43915; -.
DR   GeneWiki; C-fos_induced_growth_factor; -.
DR   GenomeRNAi; 2277; -.
DR   Pharos; O43915; Tbio.
DR   PRO; PR:O43915; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; O43915; protein.
DR   Bgee; ENSG00000165197; Expressed in right lung and 117 other tissues.
DR   Genevisible; O43915; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0042056; F:chemoattractant activity; IDA:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; TAS:ProtInc.
DR   GO; GO:0043185; F:vascular endothelial growth factor receptor 3 binding; IBA:GO_Central.
DR   GO; GO:0005172; F:vascular endothelial growth factor receptor binding; IPI:UniProtKB.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048144; P:fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0050930; P:induction of positive chemotaxis; IDA:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IBA:GO_Central.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IBA:GO_Central.
DR   GO; GO:0060754; P:positive regulation of mast cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IBA:GO_Central.
DR   GO; GO:0002040; P:sprouting angiogenesis; IBA:GO_Central.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0038084; P:vascular endothelial growth factor signaling pathway; IBA:GO_Central.
DR   CDD; cd00135; PDGF; 1.
DR   Gene3D; 2.10.90.10; -; 1.
DR   InterPro; IPR004153; CXCXC_repeat.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR023581; PD_growth_factor_CS.
DR   InterPro; IPR000072; PDGF/VEGF_dom.
DR   Pfam; PF03128; CXCXC; 1.
DR   Pfam; PF00341; PDGF; 1.
DR   SMART; SM00141; PDGF; 1.
DR   SUPFAM; SSF57501; SSF57501; 1.
DR   PROSITE; PS00249; PDGF_1; 1.
DR   PROSITE; PS50278; PDGF_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Angiogenesis; Cleavage on pair of basic residues;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Growth factor; Mitogen; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   PROPEP          22..88
FT                   /note="Or 99 (in a minor form)"
FT                   /evidence="ECO:0000269|PubMed:10542248"
FT                   /id="PRO_0000023408"
FT   CHAIN           89..205
FT                   /note="Vascular endothelial growth factor D"
FT                   /id="PRO_0000023409"
FT   PROPEP          206..354
FT                   /id="PRO_0000023410"
FT   REPEAT          222..237
FT                   /note="1; approximate"
FT   REPEAT          258..273
FT                   /note="2"
FT   REPEAT          277..293
FT                   /note="3"
FT   REPEAT          301..318
FT                   /note="4"
FT   REGION          222..318
FT                   /note="4 X 16 AA repeats of C-X(10)-C-X-C-X(1,3)-C"
FT   CARBOHYD        155
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   CARBOHYD        185
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   CARBOHYD        287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        111..153
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   DISULFID        136
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   DISULFID        142..189
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   DISULFID        145
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   DISULFID        146..191
FT                   /evidence="ECO:0000269|PubMed:21148085"
FT   HELIX           93..108
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   STRAND          110..119
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   HELIX           120..123
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   HELIX           127..129
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   STRAND          133..143
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   STRAND          152..166
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   STRAND          169..171
FT                   /evidence="ECO:0007829|PDB:2XV7"
FT   STRAND          178..192
FT                   /evidence="ECO:0007829|PDB:2XV7"
SQ   SEQUENCE   354 AA;  40444 MW;  2048D769D735173E CRC64;
     MYREWVVVNV FMMLYVQLVQ GSSNEHGPVK RSSQSTLERS EQQIRAASSL EELLRITHSE
     DWKLWRCRLR LKSFTSMDSR SASHRSTRFA ATFYDIETLK VIDEEWQRTQ CSPRETCVEV
     ASELGKSTNT FFKPPCVNVF RCGGCCNEES LICMNTSTSY ISKQLFEISV PLTSVPELVP
     VKVANHTGCK CLPTAPRHPY SIIRRSIQIP EEDRCSHSKK LCPIDMLWDS NKCKCVLQEE
     NPLAGTEDHS HLQEPALCGP HMMFDEDRCE CVCKTPCPKD LIQHPKNCSC FECKESLETC
     CQKHKLFHPD TCSCEDRCPF HTRPCASGKT ACAKHCRFPK EKRAAQGPHS RKNP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024